Stock Events

Stock Events

Regeneron Pharmaceuticals (REGN) Q3 2026 Earnings

30JulConfirmed

Q4 2025

Q1 2026

Q2 2026

Next

8.91

9.89

10.86

11.83

Details

Expected EPS

10.847155

Actual EPS

N/A

Surprise EPS

-10.85

Surprise Percent

+100%

Description

Regeneron Pharmaceuticals (REGN) will report earnings of for Q3 2026 on July 30, 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.